Pharmacological Approaches to Antitrypanosomal Chemotherapy

by Simon L Croft
Published 1999-03-01

Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis

by Philippe M. Loiseau, Sébastien Pomel, Simon L. Croft
Published 2020-09-01

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis

by Alaa Riezk, Katrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, Simon L. Croft
Published 2020-09-01

Innovations for the elimination and control of visceral leishmaniasis.

by Angamuthu Selvapandiyan, Simon L Croft, Suman Rijal, Hira L Nakhasi, Nirmal K Ganguly
Published 2019-09-01

Development of an in vitro media perfusion model of Leishmania major macrophage infection.

by Alec O'Keeffe, Lauren Hyndman, Sean McGinty, Alaa Riezk, Sudaxshina Murdan, Simon L Croft
Published 2019-01-01

Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India.

by Natalie J Dial, Simon L Croft, Lloyd A C Chapman, Fern Terris-Prestholt, Graham F Medley
Published 2022-01-01

Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India

by Natalie J. Dial, Simon L. Croft, Lloyd A. C. Chapman, Fern Terris-Prestholt, Graham F. Medley
Published 2022-01-01

Susceptibilidad in vitro a hexadecilfosfocolina (miltefosina), nifurtimox y benznidazole de cepas de Trypanosoma cruzi aisladas en Santander, Colombia

by Patricia Escobar, Katherine Paola Luna, Indira Paola Hernández, César Mauricio Rueda, María Magdalena Zorro, Simon L. Croft
Published 2009-09-01

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis

by Katrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, Mo Alavijeh, Stéphanie Braillard, Charles E. Mowbray, Simon L. Croft
Published 2021-04-01

Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs

by Alec O’Keeffe, Christine Hale, James A. Cotton, Vanessa Yardley, Kapish Gupta, Abhishek Ananthanarayanan, Sudaxshina Murdan, Simon L. Croft
Published 2020-06-01

Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India.

by Natalie J Dial, Graham F Medley, Simon L Croft, Tanmay Mahapatra, Khushbu Priyamvada, Bikas Sinha, Lucy Palmer, Fern Terris-Prestholt
Published 2021-02-01

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.

by Andrew A Voak, Andy Harris, Jose Miguel Coteron-Lopez, Iñigo Angulo-Barturen, Santiago Ferrer-Bazaga, Simon L Croft, Karin Seifert
Published 2021-03-01

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis

by Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, Andy Harris, Mo Alavijeh, Rita Silva-Pedrosa, Sandra Antunes, Isabel Mauricio, Sudaxshina Murdan, Simon L. Croft
Published 2018-08-01

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis [version 1; referees: 3 approved, 1 approved with reservations]

by Helen Ashwin, Karin Seifert, Sarah Forrester, Najmeeyah Brown, Sandy MacDonald, Sally James, Dimitris Lagos, Jon Timmis, Jeremy Mottram, Simon L. Croft, Paul M. Kaye
Published 2018-10-01

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis [version 2; referees: 3 approved, 1 approved with reservations]

by Helen Ashwin, Karin Seifert, Sarah Forrester, Najmeeyah Brown, Sandy MacDonald, Sally James, Dimitris Lagos, Jon Timmis, Jeremy C Mottram, Simon L. Croft, Paul M. Kaye
Published 2019-01-01

Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferase.

by Alex P McLatchie, Hollie Burrell-Saward, Elmarie Myburgh, Michael D Lewis, Theresa H Ward, Jeremy C Mottram, Simon L Croft, John M Kelly, Martin C Taylor
Published 2013-11-01

Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis [version 1; peer review: 2 approved]

by Sarah Forrester, Karin Siefert, Helen Ashwin, Najmeeyah Brown, Andrea Zelmar, Sally James, Dimitris Lagos, Jon Timmis, Mitali Chatterjee, Jeremy C. Mottram, Simon L. Croft, Paul M. Kaye
Published 2019-12-01

Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis

by Diana Caridha, Brian Vesely, Katrien van Bocxlaer, Byron Arana, Charles E. Mowbray, Sima Rafati, Silvia Uliana, Rosa Reguera, Mara Kreishman-Deitrick, Richard Sciotti, Pierre Buffet, Simon L. Croft
Published 2019-12-01

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

by Katrien Van Bocxlaer, Diana Caridha, Chad Black, Brian Vesely, Susan Leed, Richard J. Sciotti, Gert-Jan Wijnant, Vanessa Yardley, Stéphanie Braillard, Charles E. Mowbray, Jean-Robert Ioset, Simon L. Croft
Published 2019-12-01

An efficient and novel technology for the extraction of parasite genomic DNA from whole blood or culture

by David J Clark, Catherine M Moore, Marc Flanagan, Katrien Van Bocxlaer, Evangelia-Theophano Piperaki, Vanessa Yardley, Simon L Croft, John Tyson, Sam P Whitehouse, Jonathan O’Halloran, Sanjeev Krishna, Henry M Staines
Published 2020-02-01